Contraception
Volume 79, Issue 6 , Pages 463-468 , June 2009

Duet® for menstrual protection: a feasibility study in Zimbabwe

  • Sarah Averbach

      Affiliations

    • Clinical and Translational Science Institute, University of California San Francisco, San Francisco, CA 94107, USA
    • Corresponding Author InformationCorresponding author.
  • ,
  • Nuriye Sahin-Hodoglugil

      Affiliations

    • Women's Global Health Imperative, RTI International, San Francisco, CA 94104, USA
  • ,
  • Petina Musara

      Affiliations

    • University of Zimbabwe-University of California San Francisco Research Collaborative Programme in Women's Health, Harare, Zimbabwe
  • ,
  • Tsungai Chipato

      Affiliations

    • University of Zimbabwe-University of California San Francisco Research Collaborative Programme in Women's Health, Harare, Zimbabwe
  • ,
  • Ariane van der Straten

      Affiliations

    • Women's Global Health Imperative, RTI International, San Francisco, CA 94104, USA
    • Department of Medicine, Center for AIDS Prevention Studies, University of California San Francisco, San Francisco, CA 94105, USA

Received 30 September 2008 ,Revised 10 December 2008 ,Accepted 10 December 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This study was funded by Reprotect, Inc. (contract # P0015330) when Drs. van der Straten and Sahin-Hodoglugil were at the Department of OBGYN, University of California San Francisco. Sarah Averbach was a Doris Duke Clinical Research Fellow/UCSF CTSI Fellow. The authors are not employed by, nor do they own equity in, Reprotect, Inc.

PII: S0010-7824(08)00551-9

doi: 10.1016/j.contraception.2008.12.002

Contraception
Volume 79, Issue 6 , Pages 463-468 , June 2009